About
Lipid nanoparticle (LNP) mRNA drug delivery systems
Areas of Focus
Categories
NanotechGene Therapy, RNA & Peptide TherapyDrug Delivery & FormulationSan Diego & Southern California
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
13
As Collaborator
1
Total Enrollment
22,297
By Phase
PHASE2: 5PHASE1: 5PHASE3: 1PHASE1/PHASE2: 2PHASE2/PHASE3: 1
By Status
COMPLETED: 8TERMINATED: 3RECRUITING: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06747858Lead Sponsor
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
PHASE2Recruiting
12 participants
Started: Dec 12, 2024 · Completed: Dec 31, 2025
NCT06602531Lead Sponsor
Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults
PHASE1Active, not recruiting
212 participants
Started: Dec 10, 2024 · Completed: Dec 19, 2025
NCT06488313Lead Sponsor
A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD
PHASE2Recruiting
9 participants
Started: Nov 4, 2024 · Completed: Sep 1, 2026
NCT06279871Lead Sponsor
Immunogenicity and Safety Study of Self-amplifying mRNA COVID-19 Vaccine Administered With Influenza Vaccines in Adults
PHASE3Completed
1,514 participants
Started: Mar 27, 2024 · Completed: Nov 21, 2024
NCT06125691Lead Sponsor
Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults
PHASE1Completed
139 participants
Started: Jan 22, 2024 · Completed: Jan 7, 2025
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...